...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Veterinary Applications?
5
Aug 06, 2017 04:49AM

"So.....lymphoma is also a common and heartbreaking disease in canines.".........

Sound like a ruff diagnosis to me.........

But seriously, in Zenith's Q1 2016 slide deck there was a slide titled "Early revenue opportunities include regional licensing deals, orphan indications and animal health" that listed "Animal Health BRD4 research has indicated numerous opportunities for both companion and food animals. Pathway 1-2 years."

Also, Masila's notes from the Zenith January 7, 2016 AGM:

"We’re also looking at expansion into other indications – things move fast in oncology. One area is animal health. Things are a bit easier to get registered in this area. We may start with this in China. We’re spending very little on this and the interesting thing is that we’ve already done a lot of this research with animals to get us to where we are today."

Just to point out Masila's caveats from the beginnign of his post: "First, some caveats. Please understand that I’ve done my best to transcribe what I heard, but there’s always room for misinterpretation or forgetting something. So don’t go saying “Don said so and so at the AGM” unless you heard it yourself… I can’t guarantee I got everything right."

So at one point in the not too distant past, Zenith was interested in this animal/veterinary health field, but we haven't received an update on this in quite some time.

BearDownAZ

 

 

5
Aug 06, 2017 10:26PM
1
Aug 09, 2017 05:32AM

Aug 09, 2017 05:33AM
Share
New Message
Please login to post a reply